• BX Home
  • Business of Biotechnology: Blog [Page 4]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

BUSINESS OF BIOTECHNOLOGY

They're perfecting scientific developments that could cure the world's toughest diseases, improve food production, and even yield energy alternatives. This is the exciting world of biotechnology, where young companies fight to make innovative discoveries -- and to find new and innovative ways of funding those innovations.

Business of Biotechnology is part of Business Exchange, suggested by Arlene Weintraub. This topic contains 1,250 news and 4,718 blog items. Read updated news, blogs, and resources about Business of Biotechnology. Find user-submitted articles and reactions on Business of Biotechnology from like-minded professionals.

Blogs

Recent blog posts on this topic.

Celladon's gene therapy for heat failure takes spotlight in the U.K.more

  San Diego-based Celladon has made a big splash in the U.K. British scientists are playing a prominent role in a pair...

Biotech legend Termeer joins the board at Modernamore

Cambridge, MA-based Moderna Therapeutics has scored another coup. The biotech, which struck a major development deal...

Biotech upstart joins Big Pharma cast on high-profile 'breakthrough' s...more

Up until now, the FDA has reserved its new "breakthrough" designation for a Who's Who in drug development,...

UPDATED: Aveo shares plunge after FDA review raises fears of tivozanib...more

Regulators at the FDA have weighed the data for Aveo's tivozanib, raising a simple question that could prove vexing for...

Regado gambles on $75M IPO to pay pricey PhIII tabmore

David J. Mazzo, president and CEO of Regado Biosciences Late last year Regado Biosciences came up with a big $51...

Drug Patent Expirations for Apr 16 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Apr 24 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Apr 26 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Apr 29 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Celgene taps biotech Forma for drugs in hot field of protein homeostas...more

Forma Therapeutics has locked in another biopharma partner. The biotech giant Celgene ($CELG) and Forma have agreed to...

Drug Patent Expirations for Apr 16 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Apr 26 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

MedImmune chief taps top prospects, hunts new biologics dealsmore

Last year AstraZeneca's (NYSE:AZN) MedImmune did about 20 biologics deals, not counting the academic pacts it assembled.

Docs may find stellar Gilead/Bristol-Myers hep C combo too good to ign...more

  What if you had a great combination of rival drugs that worked in 100% of patients but one of the companies involved...

Drug Patent Expirations for Apr 14 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Apr 16 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Apr 24 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Apr 26 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Biotech Receptos trots out terms for $71M IPOmore

San Diego-based Receptos, which made known its plans to go public weeks ago, has proposed a price range of $14 to $16...

Biotech startup hustles new Alzheimer's program to the clinicmore

Back in early 2012, a number of physicians around the U.S. began fielding some unusual requests from Alzheimer's...

Johnson & Johnson, Evotec bask in Harvard's breaking diabetes disc...more

The German biotech Evotec and Johnson & Johnson ($JNJ) have the inside track on drug development based on a Harvard...

Drug Patent Expirations for Apr 14 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Apr 16 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Apr 24 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Apr 26 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Top Sources: Business of Biotechnology

  • Biotech Blog
  • News
  • Health Beat
  • frontendofinnovation.blogspot.com
  • Nature Biotechnology
  • The Biotech Weblog
  • policyinnovations.org
  • Science Progress
  • LinkedIn Answers: Technology
  • World Pharma News / Published News

Most Active Users in this Topic

see all contributors in Business of Biotechnology

Featured White Papers

Post a Job

Jobs in this Topic

Process Sciences Associate Drug Product Regeneron | Rensselaer, NY
Posted: May 8
SOFTWARE ENGINEER at exciting biotech company! Adaptive Biotechnologies | Seattle, WA
Posted: Apr 19
Chief Medical Officer (CMO) for Pharma/Biotech Epc Search International | North Carolina
Posted: Apr 18
Biotech Director of Pipeline Marketing Alpine Group | Denver, CO
Posted: May 6

Report comment contains invalid characters. ()
cancel
Search Cancel